- Home
- PCVX vs ABG Comparison
PCVX vs ABG Comparison
Compare PCVX & ABG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- ABG
- Stock Information
- Founded
- PCVX 2013
- ABG 1996
- Country
- PCVX United States
- ABG United States
- Employees
- PCVX 414
- ABG N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- ABG Retail-Auto Dealers and Gas Stations
- Sector
- PCVX Health Care
- ABG Consumer Discretionary
- Exchange
- PCVX Nasdaq
- ABG Nasdaq
- Market Cap
- PCVX 4.1B
- ABG 4.5B
- IPO Year
- PCVX 2020
- ABG N/A
- Fundamental
- Price
- PCVX $35.02
- ABG $229.34
- Analyst Decision
- PCVX Strong Buy
- ABG Hold
- Analyst Count
- PCVX 10
- ABG 7
- Target Price
- PCVX $136.50
- ABG $258.50
- AVG Volume (30 Days)
- PCVX 2.5M
- ABG 125.3K
- Earning Date
- PCVX 05-07-2025
- ABG 04-29-2025
- Dividend Yield
- PCVX N/A
- ABG N/A
- EPS Growth
- PCVX N/A
- ABG N/A
- EPS
- PCVX N/A
- ABG 20.94
- Revenue
- PCVX N/A
- ABG $17,135,800,000.00
- Revenue This Year
- PCVX N/A
- ABG $5.07
- Revenue Next Year
- PCVX N/A
- ABG $4.15
- P/E Ratio
- PCVX N/A
- ABG $10.94
- Revenue Growth
- PCVX N/A
- ABG 11.12
- 52 Week Low
- PCVX $27.66
- ABG $201.68
- 52 Week High
- PCVX $121.06
- ABG $312.56
- Technical
- Relative Strength Index (RSI)
- PCVX 52.30
- ABG 51.61
- Support Level
- PCVX $31.37
- ABG $224.16
- Resistance Level
- PCVX $33.31
- ABG $237.78
- Average True Range (ATR)
- PCVX 2.13
- ABG 5.08
- MACD
- PCVX 0.77
- ABG -0.16
- Stochastic Oscillator
- PCVX 77.80
- ABG 39.93
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About ABG Asbury Automotive Group Inc
Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 152 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly Texas, the West, the Mid-Atlantic, and the Southeast). Asbury store brands include McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated $17.2 billion of revenue in 2024 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.